Hyo Jung An1,2,3, Jong Sil Lee2,3,4, Jung Wook Yang2,3,4, Min Hye Kim4, Ji Min Na4, Dae Hyun Song5,2,3. 1. Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea. 2. lnstitute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Republic of Korea. 3. Department of Pathology, Gyeongsang National University School of Medicine, Jinju, Republic of Korea. 4. Department of Pathology, Gyeongsang National University Hospital, Jinju, Republic of Korea. 5. Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea; golgy@hanmail.net.
Abstract
BACKGROUND/AIM: RAB27A and RAB27B are involved in exosome secretion. To date, there have been many attempts to elucidate the roles of RAB27A and RAB27B in the prognosis of various cancer types. The association of RAB27A and RAB27B expression with the clinical and pathological features was evaluated in patients with stomach cancer. MATERIALS AND METHODS: A total of 360 patients who had undergone surgery for stomach cancer between January 1999 and December 2007 at Gyeongsang National University were enrolled in the study. Disease-free survival (DFS) and disease-specific survival (DSS) were compared according to immunohistochemistry of tumor samples. RAB27A and RAB27B mRNA and protein were also extracted from four stomach cancer cell lines using quantitative polymerase chain reaction and western blotting. RESULTS: Strong nuclear RAB27A expression in tumor samples was statistically significantly correlated with lymph node metastasis. Cytoplasmic RAB27B expression was related to poor disease-free survival and its combined cytoplasmic and membranous expression was related to disease-specific survival of patients with different histopathological types of stomach cancer. High RAB27A expression and high RAB27B expression was found in four stomach cancer cell blocks. Among the four cell lines, NCI-N87 exhibited the lowest relative mRNA density and HS746T exhibited the highest relative protein density for both RAB27A and RAB27B. CONCLUSION: RAB27A and RAB27B expression may help predict lymph node metastasis and survival of patients with gastric cancer. Copyright
BACKGROUND/AIM: RAB27A and RAB27B are involved in exosome secretion. To date, there have been many attempts to elucidate the roles of RAB27A and RAB27B in the prognosis of various cancer types. The association of RAB27A and RAB27B expression with the clinical and pathological features was evaluated in patients with stomach cancer. MATERIALS AND METHODS: A total of 360 patients who had undergone surgery for stomach cancer between January 1999 and December 2007 at Gyeongsang National University were enrolled in the study. Disease-free survival (DFS) and disease-specific survival (DSS) were compared according to immunohistochemistry of tumor samples. RAB27A and RAB27B mRNA and protein were also extracted from four stomach cancer cell lines using quantitative polymerase chain reaction and western blotting. RESULTS: Strong nuclear RAB27A expression in tumor samples was statistically significantly correlated with lymph node metastasis. Cytoplasmic RAB27B expression was related to poor disease-free survival and its combined cytoplasmic and membranous expression was related to disease-specific survival of patients with different histopathological types of stomach cancer. High RAB27A expression and high RAB27B expression was found in four stomach cancer cell blocks. Among the four cell lines, NCI-N87 exhibited the lowest relative mRNA density and HS746T exhibited the highest relative protein density for both RAB27A and RAB27B. CONCLUSION: RAB27A and RAB27B expression may help predict lymph node metastasis and survival of patients with gastric cancer. Copyright
Authors: Marie Stampe Ostenfeld; Dennis K Jeppesen; Jens R Laurberg; Anders T Boysen; Jesper B Bramsen; Bjarke Primdal-Bengtson; An Hendrix; Philippe Lamy; Frederik Dagnaes-Hansen; Mads H Rasmussen; Khan H Bui; Niels Fristrup; Erik I Christensen; Iver Nordentoft; Jens P Morth; Jørgen B Jensen; Jakob S Pedersen; Martin Beck; Dan Theodorescu; Michael Borre; Kenneth A Howard; Lars Dyrskjøt; Torben Falck Ørntoft Journal: Cancer Res Date: 2014-09-26 Impact factor: 12.701
Authors: Hyo Jung An; Dae Hyun Song; Hyun Min Koh; Gyung Hyuck Ko; Jeong-Hee Lee; Dong Chul Kim; Jung Wook Yang; Min Hye Kim; Deok Ha Seo; Se Min Jang; Jong Sil Lee Journal: Biomark Med Date: 2019-01-21 Impact factor: 2.851
Authors: Matias Ostrowski; Nuno B Carmo; Sophie Krumeich; Isabelle Fanget; Graça Raposo; Ariel Savina; Catarina F Moita; Kristine Schauer; Alistair N Hume; Rui P Freitas; Bruno Goud; Philippe Benaroch; Nir Hacohen; Mitsunori Fukuda; Claire Desnos; Miguel C Seabra; François Darchen; Sebastian Amigorena; Luis F Moita; Clotilde Thery Journal: Nat Cell Biol Date: 2009-12-06 Impact factor: 28.824
Authors: Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall Journal: Nat Cell Biol Date: 2007-05-07 Impact factor: 28.824